Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $48.61 USD
Change Today +0.02 / 0.04%
Volume 646.2K
ALR On Other Exchanges
Symbol
Exchange
Berlin
As of 8:04 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by ALERE INC (ALR) in the last 6 months

Announced 07/16/15
60.00M for US Diagnostics, Inc.
Merger/Acquisition

Alere Inc. (NYSE:ALR) acquired substantially all assets of USDiagnostics, Inc. for $60 million in cash on June 16, 2015. In a concurrently announced transaction, Alere will sell BBI Group to Exponent Private Equity, LLP. Alere expects the two transactions combined to be dilutive to earnings per share by approximately $0.00-$0.05 in 2015.


ALR's price was unchanged after the transaction was announced on 07/16/15.
Investor / Buyer
Alere Inc.
 
Announced 07/16/15
164.00M for BBI Diagnostics Group Plc
Merger/Acquisition

Exponent Private Equity LLP entered into an agreement to acquire BBI Group from Alere Inc. (NYSE:ALR) for approximately $160 million on July 2, 2015. The final purchase price is subject to a working capital adjustment and includes a $47 million contingent consideration. In a concurrently announced transaction, Alere acquired US Diagnostics. The transaction is subject to regulatory approvals, including applicable anti-trust authorization, approvals by Committee on Foreign ...
Read More


ALR's price was unchanged after the transaction was announced on 07/16/15.
Investor / Buyer
Exponent Private Equity LLP
Creditor / Lender
Alere Inc.
 
Announced 05/22/15
Alere Analytics, Inc.
Merger/Acquisition

Persivia acquired Alere Analytics, Inc. from Alere Inc. (NYSE:ALR) on May 22, 2015.


ALR's price was unchanged after the transaction was announced on 05/22/15.
Investor / Buyer
Persivia
Creditor / Lender
Alere Inc.
 
Announced 03/23/15
8.00M for Gesellschaft für Patientenhilfe DGP mbH
Merger/Acquisition

SHL Telemedicine Ltd. (SWX:SHLTN) agreed to acquire Gesellschaft für Patientenhilfe DGP mbH from Alere Inc. (NYSE:ALR) for €7.6 million in cash on March 23, 2015. SHL expects to finance the transaction through a combination of existing cash and new debt. Gesellschaft für Patientenhilfe made €9.2 million in total revenues in 2014 for a net profit of €0.8 million. The transaction is expected to close within a short time-frame. The acquisition is expected to be accretive ...
Read More


ALR's price was unchanged after the transaction was announced on 03/23/15.
Investor / Buyer
SHL Telemedicine Ltd.
Creditor / Lender
Alere Inc.
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALR:US $48.61 USD +0.02

ALR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bio-Rad Laboratories Inc $150.74 USD -0.07
BioMerieux €107.50 EUR +1.90
Hill-Rom Holdings Inc $56.03 USD +0.66
PerkinElmer Inc $52.92 USD +1.50
STERIS Corp $69.13 USD +0.44
View Industry Companies
 

Industry Analysis

ALR

Industry Average

Valuation ALR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.6x
Price/Book 2.8x
Price/Cash Flow 23.5x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALERE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.